Literature DB >> 19564548

Long-term risk of sustained hypertension in white-coat or masked hypertension.

Giuseppe Mancia1, Michele Bombelli, Rita Facchetti, Fabiana Madotto, Fosca Quarti-Trevano, Hernan Polo Friz, Guido Grassi, Roberto Sega.   

Abstract

It is debated whether white-coat (WCHT) and masked hypertension (MHT) are at greater risk of developing a sustained hypertensive state (SHT). In 1412 subjects of the Pressioni Arteriose Monitorate e Loro Associazioni Study, we measured office blood pressure (BP), 24-hour ambulatory BP, and home BP. The condition of WCHT was identified as office BP >140/90 mm Hg and 24-hour BP mean <125/79 mm Hg or home BP <132/82 mm Hg. Corresponding values for MHT diagnosis were office BP <140/90 mm Hg, 24-hour BP > or =125/79 mm Hg, and home BP >or =132/82 mm Hg. SHT was identified when both office and 24-hour BP means or home BP were over threshold values and normotension was under the threshold value. Subjects were reassessed 10 years later to evaluate the BP status of the various conditions defined previously. At the first examination, 758 (54.1%), 225 (16.1%), 124 (8.9%), and 293 (20.9%) subjects were normotensive, WCHT, MHT, and SHT subjects, respectively. At the second examination, 136 normotensives (18.2%), 95 WCHT (42.6%), and 56 MHT (47.1%) subjects became SHT. As compared with normotensives, adjusting for age and sex, the risk of becoming SHT was significantly higher for WCHT and MHT subjects (odds ratio: 2.51 and 1.78, respectively; P<0.0001). Similar results were obtained when the definition of the various conditions was based on home BP. Independent contributors of worsening of hypertension status were not only baseline BP, but also, although to a lesser extent, metabolic variables and age. Subjects with WCHT and MHT are at increased risk of developing SHT. This may contribute to their prognosis that appears to be worse as compared with that of normotensive subjects.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19564548     DOI: 10.1161/HYPERTENSIONAHA.109.129882

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  70 in total

1.  Masked hypertension and effort-reward imbalance at work among 2369 white-collar workers.

Authors:  P Boucher; M Gilbert-Ouimet; X Trudel; C S Duchaine; A Milot; C Brisson
Journal:  J Hum Hypertens       Date:  2017-06-22       Impact factor: 3.012

Review 2.  Clinical significance of home blood pressure and its possible practical application.

Authors:  Yutaka Imai
Journal:  Clin Exp Nephrol       Date:  2013-07-03       Impact factor: 2.801

Review 3.  Does blood pressure variability modulate cardiovascular risk?

Authors:  Peter M Rothwell
Journal:  Curr Hypertens Rep       Date:  2011-06       Impact factor: 5.369

4.  Masked hypertension and prehypertension: diagnostic overlap and interrelationships with left ventricular mass: the Masked Hypertension Study.

Authors:  Daichi Shimbo; Jonathan D Newman; Joseph E Schwartz
Journal:  Am J Hypertens       Date:  2012-03-01       Impact factor: 2.689

Review 5.  Blood Pressure Assessment in Adults in Clinical Practice and Clinic-Based Research: JACC Scientific Expert Panel.

Authors:  Paul Muntner; Paula T Einhorn; William C Cushman; Paul K Whelton; Natalie A Bello; Paul E Drawz; Beverly B Green; Daniel W Jones; Stephen P Juraschek; Karen L Margolis; Edgar R Miller; Ann Marie Navar; Yechiam Ostchega; Michael K Rakotz; Bernard Rosner; Joseph E Schwartz; Daichi Shimbo; George S Stergiou; Raymond R Townsend; Jeff D Williamson; Jackson T Wright; Lawrence J Appel
Journal:  J Am Coll Cardiol       Date:  2019-01-29       Impact factor: 24.094

Review 6.  The importance of 24-hour ambulatory blood pressure monitoring in patients at risk of cardiovascular events.

Authors:  Josep Redon
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-03-27

Review 7.  Clinical value of ambulatory blood pressure: Is it time to recommend for all patients with hypertension?

Authors:  Yalcin Solak; Kazuomi Kario; Adrian Covic; Nathan Bertelsen; Baris Afsar; Abdullah Ozkok; Andrzej Wiecek; Mehmet Kanbay
Journal:  Clin Exp Nephrol       Date:  2015-10-22       Impact factor: 2.801

8.  Alterations in diastolic function in masked hypertension: findings from the masked hypertension study.

Authors:  Yukiko Oe; Daichi Shimbo; Joji Ishikawa; Kazue Okajima; Takuya Hasegawa; Keith M Diaz; Paul Muntner; Shunichi Homma; Joseph E Schwartz
Journal:  Am J Hypertens       Date:  2013-02-27       Impact factor: 2.689

Review 9.  Unmasking masked hypertension: prevalence, clinical implications, diagnosis, correlates and future directions.

Authors:  J Peacock; K M Diaz; A J Viera; J E Schwartz; D Shimbo
Journal:  J Hum Hypertens       Date:  2014-02-27       Impact factor: 3.012

Review 10.  Management of hypertension in the elderly patient.

Authors:  Gordon Stewart Stokes
Journal:  Clin Interv Aging       Date:  2009-10-12       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.